Medical Information
For Product information or to report an adverse event, product quality complaint, or exposure to XENLETA (lefamulin) during pregnancy:
1-855-5NABRIVA, Press 1 (MON-FRI:9AM-7PM EST)
Medical.Information@Nabriva.com
Suspected adverse events may be reported to the FDA directly
1-800-FDA-1088 or www.fda.gov/medwatch
As part of our commitment to improving patient care and to advancing medical and scientific knowledge about our products, Nabriva is pleased to offer funding for independent Medical Education programs for healthcare professionals. Click below to learn more.
Investigator-Initiated Research Grants
Nabriva Therapeutics US, Inc.
1000 Continental Drive, Suite 600
King of Prussia, PA 19406
USA
View Google map
T +1 (610) 816-6640
F +1 (610) 816-6639
officeUS@nabriva.com